APA

Ardine M., Generali D., Donadio M., Bonardi S., Scoletta M., Vandone A. M., Mozzati M., Bertetto O., Bottini A., Dogliotti L. & Berruti A. (20070104). Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Ardine M, Generali D, Donadio M, Bonardi S, Scoletta M, Vandone A M, Mozzati M, Bertetto O, Bottini A, Dogliotti L and Berruti A. 20070104. Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Ardine M., Generali D., Donadio M., Bonardi S., Scoletta M., Vandone A. M., Mozzati M., Bertetto O., Bottini A., Dogliotti L. and Berruti A. (20070104). Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Ardine M, Generali D, Donadio M, Bonardi S, Scoletta M, Vandone A M, Mozzati M, Bertetto O, Bottini A, Dogliotti L and Berruti A. Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?. : Annals of oncology : official journal of the European Society for Medical Oncology. 20070104.